PSNL

Personalis, Inc. NGM · PSNL

$12.98 -0.46 (-3.42%)

Neutral · -0.43σ

+ Compare Open in Sniper

Valuation

Market cap $1.4B

P/E (ttm) —

Forward P/E -14.3

Beta (5y) 2.24

Shares out 104.7M

Div yield —

Profitability & returns

ROE -41.4%

Net margin -148.1%

FCF margin -65.6%

Debt / equity 0.15

Trading information

Last price $12.98

Day range $12.84 – $13.41

52-wk range $4.95 – $16.39

Avg volume 3.8M

RSI (2) 7.6

Trend zone Neutral

52-week range · today's price

$4.95$16.39

Company

Sector Healthcare

Industry Diagnostics & Research

Exchange NGM

Next earnings 2026-08-05

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing …